These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

155 related articles for article (PubMed ID: 28844172)

  • 21. Mitochondria-Targeted Hydroxyapatite Nanoparticles for Selective Growth Inhibition of Lung Cancer in Vitro and in Vivo.
    Sun Y; Chen Y; Ma X; Yuan Y; Liu C; Kohn J; Qian J
    ACS Appl Mater Interfaces; 2016 Oct; 8(39):25680-25690. PubMed ID: 27602785
    [TBL] [Abstract][Full Text] [Related]  

  • 22. A strategy for oral chemotherapy via dual pH-sensitive polyelectrolyte complex nanoparticles to achieve gastric survivability, intestinal permeability, hemodynamic stability and intracellular activity.
    Deng L; Dong H; Dong A; Zhang J
    Eur J Pharm Biopharm; 2015 Nov; 97(Pt A):107-17. PubMed ID: 26515259
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Pulmonary administration of a doxorubicin-conjugated dendrimer enhances drug exposure to lung metastases and improves cancer therapy.
    Kaminskas LM; McLeod VM; Ryan GM; Kelly BD; Haynes JM; Williamson M; Thienthong N; Owen DJ; Porter CJ
    J Control Release; 2014 Jun; 183():18-26. PubMed ID: 24637466
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Hypericin-functionalized graphene oxide for enhanced mitochondria-targeting and synergistic anticancer effect.
    Han C; Zhang C; Ma T; Zhang C; Luo J; Xu X; Zhao H; Chen Y; Kong L
    Acta Biomater; 2018 Sep; 77():268-281. PubMed ID: 30006311
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Matrix Metalloproteinase-Responsive Multifunctional Peptide-Linked Amphiphilic Block Copolymers for Intelligent Systemic Anticancer Drug Delivery.
    Ke W; Zha Z; Mukerabigwi JF; Chen W; Wang Y; He C; Ge Z
    Bioconjug Chem; 2017 Aug; 28(8):2190-2198. PubMed ID: 28661654
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Development of an inhalable, stimuli-responsive particulate system for delivery to deep lung tissue.
    Abbas Y; Azzazy HM; Tammam S; Lamprecht A; Ali ME; Schmidt A; Sollazzo S; Mathur S
    Colloids Surf B Biointerfaces; 2016 Oct; 146():19-30. PubMed ID: 27244047
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Revealing the Regional Localization and Differential Lung Retention of Inhaled Compounds by Mass Spectrometry Imaging.
    Hamm GR; Bäckström E; Brülls M; Nilsson A; Strittmatter N; Andrén PE; Grime K; Fridén M; Goodwin RJA
    J Aerosol Med Pulm Drug Deliv; 2020 Feb; 33(1):43-53. PubMed ID: 31364961
    [No Abstract]   [Full Text] [Related]  

  • 28. The influence of pulmonary surfactant on nanoparticulate drug delivery systems.
    Schleh C; Rothen-Rutishauser B; Kreyling WG
    Eur J Pharm Biopharm; 2011 Apr; 77(3):350-2. PubMed ID: 21195761
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Inhalable nanostructured lipid particles of 9-bromo-noscapine, a tubulin-binding cytotoxic agent: in vitro and in vivo studies.
    Jyoti K; Kaur K; Pandey RS; Jain UK; Chandra R; Madan J
    J Colloid Interface Sci; 2015 May; 445():219-230. PubMed ID: 25622047
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A toxicological evaluation of inhaled solid lipid nanoparticles used as a potential drug delivery system for the lung.
    Nassimi M; Schleh C; Lauenstein HD; Hussein R; Hoymann HG; Koch W; Pohlmann G; Krug N; Sewald K; Rittinghausen S; Braun A; Müller-Goymann C
    Eur J Pharm Biopharm; 2010 Jun; 75(2):107-16. PubMed ID: 20206256
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Paclitaxel and quercetin nanoparticles co-loaded in microspheres to prolong retention time for pulmonary drug delivery.
    Liu K; Chen W; Yang T; Wen B; Ding D; Keidar M; Tang J; Zhang W
    Int J Nanomedicine; 2017; 12():8239-8255. PubMed ID: 29180863
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Biodistribution of biodegradable polymeric nano-carriers loaded with busulphan and designed for multimodal imaging.
    Asem H; Zhao Y; Ye F; Barrefelt Å; Abedi-Valugerdi M; El-Sayed R; El-Serafi I; Abu-Salah KM; Hamm J; Muhammed M; Hassan M
    J Nanobiotechnology; 2016 Dec; 14(1):82. PubMed ID: 27993139
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Pulmonary drug delivery: a role for polymeric nanoparticles?
    d'Angelo I; Conte C; Miro A; Quaglia F; Ungaro F
    Curr Top Med Chem; 2015; 15(4):386-400. PubMed ID: 25579350
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Fluorescent carbon dot-gated multifunctional mesoporous silica nanocarriers for redox/enzyme dual-responsive targeted and controlled drug delivery and real-time bioimaging.
    Wang Y; Cui Y; Zhao Y; He B; Shi X; Di D; Zhang Q; Wang S
    Eur J Pharm Biopharm; 2017 Aug; 117():105-115. PubMed ID: 28363599
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Study on the Pulmonary Delivery System of Apigenin-Loaded Albumin Nanocarriers with Antioxidant Activity.
    Pápay ZE; Kósa A; Böddi B; Merchant Z; Saleem IY; Zariwala MG; Klebovich I; Somavarapu S; Antal I
    J Aerosol Med Pulm Drug Deliv; 2017 Aug; 30(4):274-288. PubMed ID: 28282259
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Organelle targeting: third level of drug targeting.
    Sakhrani NM; Padh H
    Drug Des Devel Ther; 2013; 7():585-99. PubMed ID: 23898223
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Drug-delivering-drug platform-mediated potent protein therapeutics
    Xin X; Teng C; Du X; Lv Y; Xiao Q; Wu Y; He W; Yin L
    Theranostics; 2018; 8(13):3474-3489. PubMed ID: 30026860
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Chemosensitizing indomethacin-conjugated chitosan oligosaccharide nanoparticles for tumor-targeted drug delivery.
    Lee JY; Termsarasab U; Lee MY; Kim DH; Lee SY; Kim JS; Cho HJ; Kim DD
    Acta Biomater; 2017 Jul; 57():262-273. PubMed ID: 28483700
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Layer-by-layer pH-sensitive nanoparticles for drug delivery and controlled release with improved therapeutic efficacy
    Men W; Zhu P; Dong S; Liu W; Zhou K; Bai Y; Liu X; Gong S; Zhang S
    Drug Deliv; 2020 Dec; 27(1):180-190. PubMed ID: 31924103
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Novel and current treatment concepts using pulmonary drug delivery.
    Hohenegger M
    Curr Pharm Des; 2010; 16(22):2484-92. PubMed ID: 20509845
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.